KIA
Kopp Investment Advisors Portfolio holdings
AUM
$54.4M
This Quarter Return
+14.5%
1 Year Return
+14.33%
3 Year Return
+109.21%
5 Year Return
+340.79%
10 Year Return
–
AUM
$112M
AUM Growth
+$112M
(+9.2%)
Cap. Flow
-$3.2M
Cap. Flow
% of AUM
-2.87%
Top 10 Holdings %
Top 10 Hldgs %
46.04%
Holding
65
New
4
Increased
20
Reduced
32
Closed
1
Top Buys
| 1 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
$906K |
| 2 |
IMPV
Imperva, Inc.
IMPV
|
$856K |
| 3 |
CyberArk
CYBR
|
$776K |
| 4 |
OCLR
Oclaro Inc.
OCLR
|
$705K |
| 5 |
CALD
Callidus Software, Inc.
CALD
|
$692K |
Top Sells
| 1 |
AKRX
Akorn, Inc.
AKRX
|
$2.45M |
| 2 |
SPS Commerce
SPSC
|
$1.55M |
| 3 |
XENT
Intersect ENT, Inc
XENT
|
$1.43M |
| 4 |
Omnicell
OMCL
|
$675K |
| 5 |
ENZ
Enzo Biochem, Inc.
ENZ
|
$480K |
Sector Composition
| 1 | Healthcare | 37.37% |
| 2 | Technology | 33.63% |
| 3 | Industrials | 3.2% |
| 4 | Financials | 2.81% |
| 5 | Consumer Discretionary | 2.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OCLR
1
DELISTED
Oclaro Inc.
OCLR
| $8.82M | 7.89% | 944,066 +75,430 | +9% | +$705K |
|
|
XENT
2
DELISTED
Intersect ENT, Inc
XENT
| $8.44M | 7.56% | 301,963 -51,288 | -15% | -$1.43M |
|
|
TLGT
3
DELISTED
Teligent, Inc
TLGT
| $5.91M | 5.29% | 646,281 -26,581 | -4% | -$243K |
|
|
SRGA
4
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $5.69M | 5.1% | 973,388 +154,922 | +19% | +$906K |
|
|
FNSR
5
DELISTED
Finisar Corp
FNSR
| $4.79M | 4.29% | 184,543 +4,818 | +3% | +$125K |
|
6
NeoGenomics
NEO
$1.13B
| $4.13M | 3.7% | 460,802 -34,080 | -7% | -$305K |
|
|
AKRX
7
DELISTED
Akorn, Inc.
AKRX
| $3.95M | 3.54% | 117,837 -72,956 | -38% | -$2.45M |
|
|
CALD
8
DELISTED
Callidus Software, Inc.
CALD
| $3.42M | 3.06% | 141,436 +28,580 | +25% | +$692K |
|
|
9
Omnicell
OMCL
$1.5B
| $3.15M | 2.82% | 72,967 -15,650 | -18% | -$675K |
|
10
Commault Systems
CVLT
$8.3B
| $3.12M | 2.8% | 55,326 +1,327 | +2% | +$74.9K |
|
|
IDTI
11
DELISTED
Integrated Device Technology I
IDTI
| $3.03M | 2.71% | 117,526 -1,751 | -1% | -$45.2K |
|
|
GIMO
12
DELISTED
Gigamon Inc.
GIMO
| $3M | 2.69% | 76,272 -1,540 | -2% | -$60.6K |
|
13
AtriCure
ATRC
$1.84B
| $2.84M | 2.54% | 116,894 -1,920 | -2% | -$46.6K |
|
|
NXTM
14
DELISTED
NxStage Medical Inc.
NXTM
| $2.75M | 2.46% | 109,546 -8,233 | -7% | -$206K |
|
15
Ligand Pharmaceuticals
LGND
$3.15B
| $2.72M | 2.44% | 22,416 -1,148 | -5% | -$139K |
|
16
Skyworks Solutions
SWKS
$11.1B
| $2.62M | 2.35% | 27,324 -452 | -2% | -$43.4K |
|
|
KTWO
17
DELISTED
K2M Group Holdings, Inc
KTWO
| $2.45M | 2.19% | 100,503 -3,386 | -3% | -$82.5K |
|
|
IMPV
18
DELISTED
Imperva, Inc.
IMPV
| $2.43M | 2.18% | 50,789 +17,887 | +54% | +$856K |
|
19
Insulet
PODD
$23.9B
| $2.34M | 2.1% | 45,663 -628 | -1% | -$32.2K |
|
20
8x8 Inc
EGHT
$270M
| $2.22M | 1.99% | 152,795 -2,305 | -1% | -$33.5K |
|
|
21
CyberArk
CYBR
$22.8B
| $2.21M | 1.97% | 44,143 +15,527 | +54% | +$776K |
|
|
ENZ
22
DELISTED
Enzo Biochem, Inc.
ENZ
| $2.2M | 1.97% | 199,132 -43,508 | -18% | -$480K |
|
23
Qorvo
QRVO
$8.4B
| $2.07M | 1.85% | 32,644 -521 | -2% | -$33K |
|
24
Supernus Pharmaceuticals
SUPN
$2.53B
| $1.97M | 1.77% | 45,782 -773 | -2% | -$33.3K |
|
25
MaxLinear
MXL
$1.37B
| $1.82M | 1.63% | 65,212 -1,338 | -2% | -$37.3K |
|